본문으로 건너뛰기
← 뒤로

OnabotulinumtoxinA for the treatment of headache: an updated review.

Journal of integrative neuroscience 2022 Vol.21(1) p. 37

Talbet JH, Elnahry AG

관련 도메인

📝 환자 설명용 한 줄

Botulinum toxin (BT) is a neurotoxin produced by Clostridium botulinum, a gram-positive anaerobic bacterium.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Talbet JH, Elnahry AG (2022). OnabotulinumtoxinA for the treatment of headache: an updated review.. Journal of integrative neuroscience, 21(1), 37. https://doi.org/10.31083/j.jin2101037
MLA Talbet JH, et al.. "OnabotulinumtoxinA for the treatment of headache: an updated review.." Journal of integrative neuroscience, vol. 21, no. 1, 2022, pp. 37.
PMID 35164473

Abstract

Botulinum toxin (BT) is a neurotoxin produced by Clostridium botulinum, a gram-positive anaerobic bacterium. Systemic human intoxication from BT following oral ingestion results in acute and life-threatening muscle paralysis called botulism. BT has a wide scope of therapeutic uses, including conditions associated with increased muscle tone, smooth muscle hyperactivity, salivation, sweating, and allergies, as well as for cosmetic purposes. Several commercial forms of BT are available for medical use, including Botox (onabotulinumtoxinA). Multiple studies have found evidence of an analgesic effect of onabotulinumtoxinA and demonstrated the benefits of its use for the treatment of various chronic pain disorders. In this review, we provide an update on the use of onabotulinumtoxinA for the treatment of headache disorders.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 1
시술 botox 보툴리눔독소 주사 dict 1

MeSH Terms

Botulinum Toxins, Type A; Headache Disorders; Humans; Neuromuscular Agents

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문